(Q42546575)

2 November 2017

title

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris (English)

1 reference

2 November 2017

A W Lucky

1

1 reference

2 November 2017

T A Henderson

2

1 reference

2 November 2017

W H Olson

3

1 reference

2 November 2017

D M Robisch

4

1 reference

2 November 2017

M Lebwohl

5

1 reference

2 November 2017

L J Swinyer

6

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Journal of the American Academy of Dermatology

2 November 2017

published in

1 reference

2 November 2017

volume

37

1 reference

2 November 2017

issue

5 Pt 1

1 reference

2 November 2017

page(s)

746-754

1 reference

Hormonal correlates of acne and hirsutism

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Current views on the aetiology, pathogenesis and treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Androgen status in women with late onset or persistent acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

An open study of Triphasil and Diane 50 in the treatment of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Anti-androgen treatment in women with acne: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970112-9

7 January 2021

10.1016/S0190-9622(97)70112-9

Identifiers

DOI

1 reference

2 November 2017

1 reference